HOOK - HOOKIPA Pharma Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5306.93M
Enterprise Value 3201.43M
Trailing P/E N/A
Forward P/E 1-5.98
PEG Ratio (5 yr expected) 11.08
Price/Sales (ttm)22.90
Price/Book (mrq)2.44
Enterprise Value/Revenue 315.03
Enterprise Value/EBITDA 6-5.34

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 321.24%
52 Week High 314.76
52 Week Low 36.06
50-Day Moving Average 312.18
200-Day Moving Average 39.10

Share Statistics

Avg Vol (3 month) 3115.68k
Avg Vol (10 day) 352k
Shares Outstanding 521.59M
Float 6.85M
% Held by Insiders 114.94%
% Held by Institutions 152.09%
Shares Short (Jan 30, 2020) 4145.8k
Short Ratio (Jan 30, 2020) 41.47
Short % of Float (Jan 30, 2020) 41.05%
Short % of Shares Outstanding (Jan 30, 2020) 40.57%
Shares Short (prior month Dec 30, 2019) 4297.67k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -258.77%
Operating Margin (ttm)-298.90%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)13.4M
Revenue Per Share (ttm)1.14
Quarterly Revenue Growth (yoy)7.30%
Gross Profit (ttm)-14.34M
EBITDA -37.72M
Net Income Avi to Common (ttm)-34.69M
Diluted EPS (ttm)-2.96
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)123.69M
Total Cash Per Share (mrq)4.87
Total Debt (mrq)12.59M
Total Debt/Equity (mrq)10.01
Current Ratio (mrq)10.53
Book Value Per Share (mrq)4.95

Cash Flow Statement

Operating Cash Flow (ttm)-39.31M
Levered Free Cash Flow (ttm)N/A